Publications by authors named "S W Dusza"
Melanoma of the lentigo maligna (LM) type is most commonly located on the head and neck region. This subtype of melanoma poses surgical challenges due to its location on anatomically sensitive areas and frequent presence of subclinical extension. To analyze the reconstruction patterns of LM patients undergoing margin-controlled surgery.
View Article and Find Full Text PDFBackground: Differentiating melanoma (MM) from seborrheic keratosis (SK) containing a blue-white veil (BWV) remains challenging.
Objective: Identify dermoscopic features that can improve upon the differentiation between MMs and SKs exhibiting BWV.
Methods: Images from 110 MMs and 121 SKs containing BWV were aggregated, and 91 MMs and 62 SKs from this data set had complete agreement on the presence of BWV according to 3 expert dermoscopists.
Article Synopsis
- The study focuses on establishing Minimal Important Difference (MID) estimates for the FACE-Q Skin Cancer Module, a tool to measure patient outcomes after facial skin cancer surgery.
- Conducted at four U.S. hospitals from April 2020 to April 2022, 990 patients undergoing Mohs Micrographic Surgery provided data through various scales assessing satisfaction and distress at multiple time points.
- The findings indicated specific MID estimates for the scales, which are key for improving the understanding and application of patient-reported outcomes in clinical settings.
Article Synopsis
- Paclitaxel is a common treatment for breast, ovarian, and lung cancers, but its use can be hindered by hypersensitivity reactions, potentially affecting about 11.9% of patients.
- A study at Memorial Sloan Kettering analyzed 12,274 patients, revealing that factors like younger age, race, and allergy history were significant predictors of these immediate and delayed reactions, particularly in breast cancer patients.
- Understanding these risk factors can help healthcare providers make better treatment decisions and consider alternatives like switching to nab-paclitaxel if patients experience troublesome skin reactions.